OC
UTMD icon

Optima Capital’s Utah Medical Products UTMD Stock Holding History

Optima Capital’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$506 – 1241
2025
Q4 		$506 Buy
+9
New +$522 ﹤0.01% 1227

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Optima Capital's UTMD Position: Q1 2026 in Review

Optima Capital sold out of Utah Medical Products (UTMD) in Q1 2026, closing a stake of 9 shares — an estimated $506 sold.

Optima Capital first reported a position in UTMD in Q4 2025 and held it in 1 quarter. The position peaked at $506 in Q4 2025. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Optima Capital reported no remaining Utah Medical Products position as of Q1 2026 after selling out during the quarter.
  • Optima Capital sold 9 Utah Medical Products shares in Q1 2026, an estimated $506.
  • Optima Capital first reported a position in Utah Medical Products in Q4 2025 and held it in 1 quarter.
  • Optima Capital's Utah Medical Products position peaked at $506 in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.